Innov'nCare Email Formats
Biotechnology Research • 
Institut de Biologie en Santé IRIS-1 47-49 rue des Capucins, Angers, France • 1-10 Employees
Key Contact at Innov'nCare
Claire Lépinoux-Chambaud
Research Director & Co-founder
Company overview
| Headquarters | Institut de Biologie en Santé IRIS-1 47-49 rue des Capucins, Angers, Pays de la Loire 49100, FR |
| NAICS | 541714 |
| Keywords | Cancer, Rare Diseases, Stem Cells, Peptide, Neurodegenerative Diseases, Neurooncology, Vectorization, Brain Tumors, Pediatric Cancer, Nanomedicines |
| Founded | 2025 |
| Employees | 1-10 |
About Innov'nCare
Innov’nCare is a deeptech startup developing a next-generation therapeutic vectorization platform. Its mission: to enable the precise delivery of treatments to stem cells — including cancer stem cells — to enhance therapeutic efficacy and long-term outcomes. Innov’nCare was co-founded by two scientists with complementary backgrounds: Claire Lépinoux-Chambaud, PhD in Neuroscience and co-author of the patent protecting the developed technology, and Clément Sanchez, PhD in Medicinal Chemistry. Together, they bring cross-disciplinary expertise in medicinal chemistry, cell biology, pharmaceutical and pharmacological development, and analytical sciences. They are jointly developing a unique platform capable of selectively delivering therapeutic agents to stem cells, the most resistant and critical cell populations in a wide range of diseases, particularly cancers. This breakthrough opens new avenues for targeted and personalized therapies, while minimizing side effects.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Innov'nCare has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Innov'nCare has never raised funding before.
South Africa
United Kingdom
United States
Frequently asked questions
4.8
40,000 users
